MTVA: Biji pasar MetaVia Inc

The price action history of MetaVia Inc (MTVA), which specializes in neuromedicine, is recorded at 0.01. Rate fluctuations are driven by clinical trial costs, which necessitate strict expenditure oversight. Meanwhile, drug synthesis is delegated to third-party contractors in the US, minimizing technical disruptions. The business is resilient to market downturns, reacting only to changes in Fed interest rates.

MetaVia Inc. - Kapitalisasi pasar MTVA (periode 23.10.2026 - 23.10.2026)

MTVA (metaviatx.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji MetaVia Inc (MTVA):

Kutipan saham MetaVia|MTVA - Rega prakiraan analis|Biji pasar MetaVia

Analisis fundamental perusahaan:MTVA (MetaVia, Inc.)

Sampel barang MetaVia Inc.

Market capitalization reflects the aggregate value of all MetaVia Inc. shares, determining the company's weight within its sector. This indicator allows for an assessment of the business's fundamental value and the risk of overpaying for the asset. By analyzing changes in the company's market capitalization, an investor can gauge market confidence in the issuer. For MTVA, value dynamics depend directly on successes in Alzheimer's disease therapy. The potential for insurance funds to purchase these drugs drives the future growth of this metric.

Pesaing wigati

Biogen - Biji pasar|Nilai pasar NBIX (Neurocrine)|RGC: Biji pasar|AXSM: Nilai pasar|ACAD: Kapitalisasi pasar|xenon-pharma.com (XENE) - Kapitalisasi pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|Biji pasar Prothena Corp (PRTA)|Kapitalisasi pasar ALEC|ANNX - Nilai pasar|Omeros - Biji pasar|Nilai pasar NGNE (Neurogene Therapeutics)|AC Immune - Kapitalisasi pasar|VYGR - Kapitalisasi pasar|NMRA (Neumora Therapeutics, Inc.) - Biji pasar|SCLX (Scilex Holding) - Nilai pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Alpha Cognition Corp (ACOG) - Kapitalisasi pasar|Kapitalisasi pasar CGTX|Kapitalisasi pasar inhibikase.com (IKT)|Cassava Sciences - Biji pasar|Nilai pasar ASRT|Coya - Kapitalisasi pasar|Kapitalisasi pasar Vistagen Therapeutics VTGN|ovidrx.com (OVID) - Nilai pasar|Kapitalisasi pasar ABOS|CRVO (CervoMed) - Kapitalisasi pasar|Biji pasar Alterity Therapeutics Ltd (ATHE)|Nilai pasar Clene Inc. (CLNN)|Biji pasar pepgen.com PEPG|Jupiter Neurosciences - Biji pasar|Nilai pasar RLMD (relmada.com)|ANVS: Biji pasar|GRCE: Nilai pasar|AIFF: Kapitalisasi pasar|Klotho Neurosciences (KLTO) - Kapitalisasi pasar|Nilai pasar NeuroSense Therapeutics Ltd|Kapitalisasi pasar RVPH (revivapharma.com)|Kapitalisasi pasar NRXS|HSDT - Nilai pasar|Passage Bio - Biji pasar|Kapitalisasi pasar Neuphoria Therapeutics, Inc. NEUP|NERV - Nilai pasar|Nilai pasar ATHA (athira.com)|Addex Therapeutics Ltd (ADXN) - Nilai pasar|Nilai pasar Alzamend Neuro (ALZN)|Nilai pasar Cyclerion Therapeutics Inc.|Biji pasar Protagenic (PTIX)|Kapitalisasi pasar KTTA|CRGT - Nilai pasar|Avenue Therapeutics, Inc. - Biji pasar|Nilai pasar BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Kapitalisasi pasar|CHRO - Kapitalisasi pasar|ELYM (eliemtx.com) - Biji pasar|ITCI (Intra-Cellular Therapies, Inc.) - Nilai pasar|LBPH (Longboard Pharmaceuticals, Inc.) - Kapitalisasi pasar|Marinus Pharmaceuticals Inc (MRNS) - Kapitalisasi pasar|Kapitalisasi pasar NKGN|Kapitalisasi pasar NeuroBo Pharma (NRBO)|Sage Therapeutics, Inc. - Biji pasar|Nilai pasar SNPX|Trevena - Kapitalisasi pasar|Kapitalisasi pasar Vigil Neuroscience VIGL|Anew Medical, Inc. (WENA) - Nilai pasar|Kapitalisasi pasar CERE